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Hereditary spherocytosis (HS) is a common pediatric hemolytic anemia and one of the most common
types of familial hemolytic anemia caused by congenital red blood cell defects. HS often presents clin-
ically as childhood anemia, jaundice, and progressive splenomegaly. It is generally accepted that sple-
nectomy is the most effective treatment for HS, but development of overwhelming infections with
symptoms such as chills, high fever, and septicemia may occur because of immune dysfunction after
splenectomy. As a result, the generally proposed age for children to undergo splenectomy is after 5 years
of age. Splenectomy in younger HS patients is rarely reported. Here, however, we report 2 cases of HS in
children younger than 2 years of age (15 months and 18 months) who underwent splenectomy; we also
report on their follow-up.
 2015 The Authors. Published by Elsevier Inc. All rights reserved.1. Case reports
1.1. Case 1
A 15-month-old girl was referred to our hospital in August 2003
with chronic anemia and paleness of a year’s duration. Her eryth-
rocyte fragility test was positive. She had received repeated red
blood cell (RBC) transfusions because of severe anemia before
entering our hospital. The interval between the transfusions had
been shortened to 2 weeks, but the symptoms of anemia did not
improve. In terms of family history, the patient’s mother had un-
dergone splenectomy for hereditary spherocytosis (HS) at 2 years of
age and the patient’s father had also undergone splenectomy
because of a traumatic splenic rupture. The patient’s physical ex-
amination showed no splenomegaly and blood tests showed that
her white blood cell countwas 11.6109 cells/L, hemoglobin 64 g/L,
RBC count 2.19  1012 cells/L, hematocrit 18.6%, and platelet count
259.00  109 cells/L. Because the patient’s parents were insistent
that their daughter undergo a splenectomy, we performed a lapa-
roscopic splenectomy when the patient’s hemoglobin increased to
85 g/L. During the operation, the spleenwas about 10  8 6 cm in
size; it was completely resected, and the patient received 150 mL ofBY-NC-ND license (http://
Published by Elsevier Inc. All rightRBCs and 100 mL of plasma. After the operation, we used penicillin
sodium combined with metronidazole and Claforan as anti-in-
fectives and monitored the patient’s blood work every day. Her
postoperative hemoglobin level was between 120 and 135 g/L, her
RBC count returned to normal on the second day after the opera-
tion, and her platelet levels reduced to normal level aweek after the
operation. The patient received a prophylactic pneumococcal vac-
cine injection after leaving the hospital. The 10-year follow-up
results were satisfying: her development was the same as healthy
children of the same age; she had no serious outbreak of infection,
jaundice, or anemia; and no coagulation disorders.1.2. Case 2
An 18-month-old boy diagnosed with HS underwent a sple-
nectomy in our hospital in June 2012 because of repeated episodes
of jaundice and paleness. A peripheral blood smear showed
spherical RBCs, and the erythrocyte fragility test was positive. The
patient received transfusions of RBCs every 2 months. With the
exacerbation of anemia, the interval time between transfusions was
shortened to 10 days. Physical examination showed splenomegaly
(about 10 cm to the rib, the lower boundary near the left groin, and
the right boundary crossed over the ventrimeson) but no splenic
hypalgesia. The blood tests showed that his white blood cell count
was 11.98  109 cells/L, hemoglobin 52 g/L, RBC count 2.36  1012
cells/L, platelets 64.00  109 cells/L, and reticulocyte count 4.17%.s reserved.
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improve. His hemoglobin levels were 59 g/L and 46 g/L during 2
evaluations. At the same time, the patient had a hemolytic crisis,
including persistent jaundice, pale face, and soy-colored urine.
Considering that long-term repeated transfusions increased his
risk, we performed a splenectomy when his hemoglobin level rose
to 79 g/L. During the operation, the spleenwas completely resected
and the patient was transfusedwith 150mL of RBCs for support.We
routinely performed prophylactic infection and hemostatic treat-
ments and checked his postoperative blood tests daily. Post-
operatively, the patient’s hemoglobin level stayed between 120 and
140 g/L and his RBC count rose remarkably; his platelet count rose
and achieved to 415109 cells/L at the ﬁfth day after the operation.
At that time, the patient started to take dipyridamole and aspirin
and continued to take them after leaving the hospital to avoid
thrombosis. The patient has been followed regularly and his platelet
level was slightly higher than the normal level at his last follow-up.
Jaundice no longer occurs, and both development and wound
healing are favorable. Standard blood tests and coagulation func-
tion results are not abnormal, and symptoms of infection no longer
occur.
2. Discussion
HS is an autosomal-dominant genetic disease. There is no sig-
niﬁcant difference in the prevalence rate between male and female
patients, and it often occurs in several members or several gener-
ations of the same family. Das and Ananthakrishnan [1] reported HS
incidence affecting 13 family members.
In the ﬁrst case, a family history of HS was present; the patient’s
mother underwent splenectomy because of HS at age 2 years.
Interestingly, the girl’s father also underwent splenectomy, but
because of traumatic splenic rupture, which gave us conﬁdence in
our prognosis for splenectomy in their daughter, despite her young
age. Additionally, the parents’ understanding of splenectomy and
their active cooperation regarding the operation were positive
conditions for a successful operation and recovery.
Splenectomy is the most basic treatment for HS at present.
However, the spleen is an important immune organ, and early
removal may lead to a low level of immunity that can lead to
overwhelming postsplenectomy infection and penicillin-resistant
pneumococcal infection [2]. As a result, for HS patients, especially
those with mild or moderate HS, the age of splenectomy remains
controversial. Some scholars think that the risk of severe infection
after splenectomy is quite large for patients younger than age 5 and
especially for patients who are younger than age 2 years because of
an inherent inability to produce antibodies against polysaccharide
antigens. These children are particularly susceptible to encapsu-
lated bacterial infections that can easily develop into a fulminant
infection [3].
One report showed that the probability of septicemia in children
who underwent splenectomy before 5 years of age was about
60e100 times greater than in children who have a spleen [4]. It is
generally believed that the appropriate age for splenectomy is after
5 years of age and that it is even better if patients are older than 6
years of age [5]. A recent single, large study reviewed 1657 HS pa-
tients who underwent splenectomy; the minimum age of these
patients was 5 years and the maximum age was 12 years. Only 1.5%
of them had urinary complications and 1.1% had respiratory com-
plications, which proved that the effect of the treatment was
remarkable [6].
There is no literature reporting patients undergoing splenec-
tomy before age 2. Our 2 patients were 15 months and 18months at
the time of splenectomy. Both were younger than the minimumaccepted age for splenectomy, which most scholars generally agree
is age 2, and both patients have shown a signiﬁcantly positive
treatment effect during follow-up.
Although vaccination and penicillin or other antibiotic use at the
early stages after surgery can effectively reduce the incidence of
infection, it cannot completely eliminate the possibility of infection
[7,8]. Both patients in this article were administered penicillin and
penicillin combined with antibiotics to strengthen anti-infection
treatment before the operation. The ﬁrst patient additionally
received a pneumococcal vaccine after discharge. Neither patient
has developed a severe infection.
The platelet count often rises transiently after splenectomy,
which can cause coagulation hyperfunction and lead to venous
thrombosis, especially splenic vein thrombosis. As a result, platelet
count should be one of the routinely monitored tests after sple-
nectomy. It is the key to preventing portal vein thrombosis effec-
tively after a splenectomy. Our ﬁrst patient had a rising platelet
count the fourth day after the operation. Her blood tests were
monitored every 2 days after leaving the hospital; 1 week later, her
platelet level had returned to normal without any treatment. The
second patient’s platelet level increased gradually on the ﬁfth day
after splenectomy and peaked 2 weeks after the operation. He was
administrated dipyridamole and aspirin continuously to prevent
thrombosis. Even now, his platelet level is slightly higher than
normal, but the overall curative effect is satisfying.
Moreover, partial splenectomy has been proposed for the
treatment of HS in recent years because it can ease anemia while
preserving splenic immune function, and thus decreasing the risk of
OPSI (overwhelming post-splenectomy sepsis). Seims et al., rec-
ommended partial splenectomy for children below the age of six
[9]. Undoubtfully, partial splenectomy is a feasible and safe option
for young HS patients. However, a report showed that partial
splenectomy has associated risks of remnant spleen regrowth,
splenomegaly recurrence and the possibility of a second operation a
few years later [10]. Taking into considerations of the possibility of
these complications, we did not perform partial splenectomy on
these two cases.
3. Conclusion
Based on the success of these two cases and the experiences of
the ﬁrst patient’s mother, we believe splenectomy could be
considered as a solution for children below the age of two years
with severe HS, who need frequent transfusion or have developed
hemolytic crisis. However, because we have reported only two
cases of splenectomy for children under two, both with only a
relatively short follow-up period, our conclusion requires more
samples and better follow-up results to be further veriﬁed.
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